Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

39.73
Delayed Data
As of Mar 28
 +0.16 / +0.40%
Today’s Change
25.98
Today|||52-Week Range
41.65
-1.17%
Year-to-Date
No recent news for Haemonetics Corp.

Today’s Trading

Previous close39.57
Today’s open39.52
Day’s range39.17 - 39.74
Volume202,445
Average volume (3 months)342,278
Market cap$2.1B
Dividend yield--
Data as of 4:02pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)-440.62%
Earnings growth (this year)-6.95%
Earnings growth (next 5 years)+8.50%
Revenue growth (last year)+0.02%
P/E ratio128.2
Price/Sales1.97
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
HYHHalyard Health Inc-0.21-0.55%
NXTMNxStage Medical Inc-0.20-0.74%
PODDInsulet Corp+0.08+0.19%
ICUIICU Medical Inc-1.15-0.74%
Data as of 4:02pm ET, 03/28/2017

Financials

Next reporting dateMay 1, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$910.5M
Annual profit (last year)-$55.6M
Net profit margin-6.10%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Christopher Simon
Executive Vice President-
Global Operations
Neil Ryding
Corporate headquarters
Braintree, Massachusetts

Forecasts


Search for Jobs